Godrej Agrovet Limited — Investor Meet, 11-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Godrej Agrovet delivered strong Q3 FY26 results with 11% YoY revenue growth and a 23% jump in PBT. Animal Feed volumes surged 12%, led by cattle feed at 21%, while Vegetable Oil revenue grew 27% with an improved 21% oil extraction ratio. Astec LifeSciences achieved a notable turnaround, becoming EBITDA positive at INR 5 Cr on 33% revenue growth, targeting FY26 breakeven.

Management is actively pursuing a strategic portfolio review, focusing on capital allocation and growth drivers, with communication expected by early April. Key shifts include a focus on branded value-added products in Foods and Dairy, and product diversification in Crop Protection with new launches. Pet food plant commissioning is imminent. The sentiment is confident on strategic pivots and the recovery of Astec.